Phil Knight's $2 Billion Donation: Revolutionizing Cancer Research at OHSU

Phil Knight, the co-founder of Nike, has pledged a generous $2 billion donation to the Oregon Health and Science University’s Cancer Institute, marking the largest single donation ever made to a U.S. university, college, or health institution. The Knight Foundation announced this significant gift, which aims to revolutionize the scientific approach to cancer treatment, research, and patient care outcomes. Phil and Penny Knight will collaborate with cancer research pioneer Dr. Brian Druker as part of this transformative initiative.
Ten years ago, Dr. Druker and OHSU embarked on a fundraising challenge to raise $500 million for cancer research, with the Knights committing to match the funds raised dollar-for-dollar. The Knights expressed their gratitude for the opportunity to invest in the next phase of Dr. Druker's groundbreaking vision for cancer research, diagnosis, treatment, care, and ultimately, eradication. They are enthusiastic about the potential impact of this work on humanity.
Phil Knight's wealth is attributed to his success with Nike, the company he established in 1964. Originally known as Blue Ribbon Sports, Nike started modestly, with Knight selling sneakers out of his car trunk. Following its IPO in December 1980, Nike quickly became a dominant sneaker brand, partnering with top athletes across various sports. During Knight's tenure at Nike, which lasted until his retirement in June 2016, the company's shares surged by almost 30,500%.
Despite facing challenges in recent years, with Nike's stock declining by over 50% from its peak in late 2021, the company remains the most valuable public entity in athletic footwear, boasting a value exceeding $110 billion. Phil and Penny Knight are recognized as prominent philanthropists, with Time Magazine estimating their lifetime giving at $3.6 billion, including a substantial $370 million donation in 2024 alone. The Knight Foundation's latest tax records indicate assets exceeding $5 billion by the end of 2023.
In his 2016 memoir, "Shoe Dog," Phil Knight reflected on his desire to create something meaningful and impactful. His philanthropic endeavors, including the recent $2 billion donation to OHSU's Cancer Institute, exemplify his commitment to making a difference in the world. The Knights' generosity and dedication to advancing cancer research and patient care underscore their significant contributions to society.